Pharma stocks are down, but is this a golden buying opportunity? With India's booming sector and low P/E stocks in focus, ...

Merck MRK stock has declined 7.8% in the past month — in roughly the span after it announced fourth-quarter 2024 results and ...

According to U.S. health officials, the number of acute respiratory illnesses causing people to seek medical care remains at ...

Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.

According to U.S. health officials, the number of acute respiratory illnesses causing people to seek medical care remains at a high level.

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

Pharmaceutical companies are investing heavily in research and development to create advanced and efficient drug delivery devices, further fueling market growth in South Korea. One of the significant ...

Amid one of the largest measles outbreaks in the United States in nearly a decade, anti-vaccine activists are promoting false ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...

Global Breath Analyzers Market is valued at USD 1.3 Billion in 2022. Global Breath Analyzers Market valuation to reach USD ...

Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement. HealthDay News — For patients with obesity undergoing joint replacement ...

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...